EP Patent

EP2506842B1 — Formulations, salts and polymorphs of transnorsertraline and uses thereof

Assigned to Sumitomo Pharma America Inc · Expires 2015-01-21 · 11y expired

What this patent protects

Patent listed against rasagiline-mesylate.

Drugs covered by this patent

rasagiline-mesylate (RASAGILINE MESYLATE)

Patent Metadata

Patent number: EP2506842B1
Jurisdiction: EP
Classification: —
Expires: 2015-01-21
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma America Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.